News | April 02, 2024
Apotex to acquire Canadian Searchlight Pharma
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Application based on results from the TROPION-Breast01 Phase III trial
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Hepatitis B infects over 40 million people in India
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Subscribe To Our Newsletter & Stay Updated
